Audit of community‐based anticoagulant monitoring in patients with thromboembolic disease: is frequent testing necessary?
- 10 November 2004
- journal article
- research article
- Published by Wiley in Internal Medicine Journal
- Vol. 34 (11), 639-641
- https://doi.org/10.1111/j.1445-5994.2004.00690.x
Abstract
Oral anticoagulant monitoring is managed by general practitioners in Auckland. An audit of this service in 452 patients demonstrated that anticoagulant control was in line with recommended international guidelines, with 58.3% of international normalized ratio (INR) measurements in the therapeutic range. However, the frequency of testing was high, with the majority of patients (68%), including those on long‐term treatment, having INR measurements at weekly intervals. We question the need for such frequent INR testing. (Intern Med J 2004; 34: 639−641)Keywords
This publication has 7 references indexed in Scilit:
- Warfarin Dose Reduction vs Watchful Waiting for Mild Elevations in the International Normalized Ratio*Chest, 2003
- Recommendations for patients undertaking self management of oral anticoagulationBMJ, 2001
- INR: Intervals of measurement can safely extend to 14 weeksClinical and Laboratory Haematology, 2000
- Quality of Anticoagulation Management Among Patients With Atrial FibrillationArchives of Internal Medicine, 2000
- Guidelines on oral anticoagulation: third editionBritish Journal of Haematology, 1998
- Optimal Frequency of Patient Monitoring and Intensity of Oral Anticoagulation Therapy in Valvular Heart DiseaseJournal of Thrombosis and Thrombolysis, 1998
- Audit of anticoagulant therapy.Journal of Clinical Pathology, 1996